These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 3250156)

  • 1. [Age-related modification of dopaminergic-cholinergic neuronal interaction in rats].
    Kishimoto O
    Yakubutsu Seishin Kodo; 1988 Dec; 8(4):443-51. PubMed ID: 3250156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effects of bifemelane on central dopaminergic and cholinergic systems in rats].
    Ushijima I; Tsutsumi C; Hara T; Soeda K; Kishimoto O; Kaneyuki H; Mizuki Y; Yamada M
    Yakubutsu Seishin Kodo; 1988 Dec; 8(4):463-70. PubMed ID: 2907957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modification of apomorphine-, physostigmine- and pilocarpine-induced yawning after long-term treatment with neuroleptic or cholinergic agents.
    Ushijima I; Noda Y; Mizuki Y; Yamada M
    Arch Int Pharmacodyn Ther; 1984 Oct; 271(2):180-8. PubMed ID: 6150689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Direct evidence for involvement of dopaminergic inhibition and cholinergic activation in yawning.
    Yamada K; Furukawa T
    Psychopharmacology (Berl); 1980 Jan; 67(1):39-43. PubMed ID: 6768077
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characteristics of yawning behavior induced by apomorphine, physostigmine and pilocarpine.
    Ushijima I; Mizuki Y; Imaizumi J; Yamada M; Noda Y; Yamada K; Furukawa T
    Arch Int Pharmacodyn Ther; 1985 Feb; 273(2):196-201. PubMed ID: 4004417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of age on behavioral responses to dopamine agonists in the rat.
    Ushijima I; Mizuki Y; Soeda K; Kishimoto O; Hara T; Yamada M
    Eur J Pharmacol; 1987 Jun; 138(1):101-6. PubMed ID: 2887433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multifocal sites of action involved in dopaminergic-cholinergic neuronal interactions in yawning.
    Ushijima I; Mizuki Y; Yamada M
    Psychopharmacology (Berl); 1988; 95(1):34-7. PubMed ID: 3133698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Muscarinic and nicotinic effects on yawning and tongue protruding in the rat.
    Ushijima I; Yamada K; Inoue T; Tokunaga T; Furukawa T; Noda Y
    Pharmacol Biochem Behav; 1984 Aug; 21(2):297-300. PubMed ID: 6541344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Behavioral effects of chronic apomorphine, and D-1/D-2 dopamine receptor activities in rats].
    Minematsu N
    Nihon Shinkei Seishin Yakurigaku Zasshi; 1995 Jun; 15(3):247-52. PubMed ID: 7584718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pre- and post-synaptic dopaminergic receptors involved in apomorphine-induced yawning.
    Urba-Holmgren R; Holmgren B; Anias J
    Acta Neurobiol Exp (Wars); 1982; 42(2):115-25. PubMed ID: 6891988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modifications on dopaminergic and cholinergic systems induced by the water tank technique: analysis through yawning behavior.
    Neumann BG; Troncone LR; Braz S; Tufik S
    Arch Int Pharmacodyn Ther; 1990; 308():32-8. PubMed ID: 2099135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Yawning induced by apomorphine, physostigmine or pilocarpine is inhibited by electroconvulsive shock (ECS).
    Wielosz M; Szymczyk H
    Acta Physiol Hung; 1996; 84(4):473-5. PubMed ID: 9328636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The modulatory role of M2 muscarinic receptor on apomorphine-induced yawning and genital grooming.
    Gamberini MT; Bolognesi ML; Nasello AG
    Neurosci Lett; 2012 Dec; 531(2):91-5. PubMed ID: 23041487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two distinctive apomorphine-induced phenotypes in the Roman high- and low-avoidance rats.
    Giménez-Llort L; Cañete T; Guitart-Masip M; Fernández-Teruel A; Tobeña A
    Physiol Behav; 2005 Nov; 86(4):458-66. PubMed ID: 16154604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction of cholinergic and dopaminergic influences on yawning behavior.
    Holmgren B; Urbá-Holmgren R
    Acta Neurobiol Exp (Wars); 1980; 40(3):633-42. PubMed ID: 6969021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of cholinergic agonists on apomorphine-induced stereotyped behavior in the rat.
    Sahakian BJ; Growdon JH; Millington WR; Barr JK; Wurtman RJ
    Commun Psychopharmacol; 1978; 2(3):255-62. PubMed ID: 568059
    [No Abstract]   [Full Text] [Related]  

  • 17. Yawning induced by apomorphine, physostigmine or pilocarpine is potentiated by dihydropyridine calcium channel blockers.
    Bourson A; Moser PC
    Psychopharmacology (Berl); 1990; 100(2):168-72. PubMed ID: 1689500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apomorphine produced more yawning in Sprague-Dawley rats than in F344 rats: a pharmacological study.
    Tang AH; Himes CS
    Eur J Pharmacol; 1995 Sep; 284(1-2):13-8. PubMed ID: 8549616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of ageing on the behavioural responses to dopamine agonists: decreased yawning and locomotion, but increased stereotypy.
    Stoessl AJ; Martin-Iverson MT; Barth TM; Dourish CT; Iversen SD
    Brain Res; 1989 Aug; 495(1):20-30. PubMed ID: 2570627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Electrophysiological and behavioral assessments of dopamine autoreceptor activation to apomorphine in rats.
    Okuyama S; Shimamura H; Hashimoto S; Aihara H
    Arch Int Pharmacodyn Ther; 1986 Dec; 284(2):246-54. PubMed ID: 3827410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.